ADVFN ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
NuCana PLC

NuCana PLC (NCNA)

0.0508
0.0006
(1.20%)
0.0499
-0.0009
( -1.77% )

NuCana PLC (NCNA) Cotización

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
0.0499
( -0.60% )
Postura de Compra
0.0499
Postura de Venta
0.05
Volume Operado de la Acción
83,959,389
0.0485 Rango del Día 0.0536
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
0.0502
Precio de Apertura
0.05
Última hora de negociación
18:44:22
Volumen financiero
US$ 4,201,865
Precio Promedio Ponderado
0.050046
Volumen promedio (3 m)
-
Acciones en circulación
8,529,891
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.02
Beneficio por acción (BPA)
-2.23
turnover
-
Beneficio neto
-19M

Acerca de NuCana PLC

NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of ... NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
London, Gbr
Fundado
-
NuCana PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NCNA. The last closing price for NuCana was US$0.05. Over the last year, NuCana shares have traded in a share price range of US$ 0.00 to US$ 0.00.

NuCana currently has 8,529,891 shares in issue. The market capitalisation of NuCana is US$428,200.53 . NuCana has a price to earnings ratio (PE ratio) of -0.02.

NCNA Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

NCNA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de NuCana?
El precio actual de las acciones de NuCana es US$ 0.0499
¿Cuántas acciones de NuCana están en circulación?
NuCana tiene 8,529,891 acciones en circulación
¿Cuál es la capitalización de mercado de NuCana?
La capitalización de mercado de NuCana es USD 428.2k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de NuCana?
NuCana ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de NuCana?
El ratio precio/beneficio de NuCana es -0.02
¿Cuál es la moneda de reporte de NuCana?
NuCana presenta sus resultados financieros en GBP
¿Cuál es el último beneficio anual de NuCana?
El último beneficio anual de NuCana es GBP -19M
¿Cuál es la dirección registrada de NuCana?
La dirección registrada de NuCana es 77 78 CANNON STREET, ENGLAND, LONDON, EC4N 6AF
¿En qué sector industrial opera NuCana?
NuCana opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
XXII22nd Century Group Inc
US$ 7.13
(55.68%)
1.25M
SRPTSarepta Therapeutics Inc New
US$ 24.58
(33.73%)
9.93M
DPRODraganfly Inc
US$ 6.82
(31.66%)
4.14M
ABVEAbove Food Ingredients Inc
US$ 2.06
(22.62%)
3.54M
ZBAIATIF Holdings Ltd
US$ 0.781
(17.98%)
3.87M
CGBSCrown LNG Holdings Ltd
US$ 0.0152
(-59.03%)
121.64M
YHCLQR House Inc
US$ 8.75
(-18.45%)
4.11M
IMRNImmuron Ltd
US$ 1.60
(-14.44%)
6.39k
ZVSAZyVersa Therapeutics Inc
US$ 0.2742
(-11.92%)
3.36M
GAMEGameSquare Holdings Inc
US$ 2.05
(-11.26%)
4.59M
CGBSCrown LNG Holdings Ltd
US$ 0.0152
(-59.03%)
121.64M
OPENOpendoor Technologies Inc
US$ 1.56
(4.70%)
26.52M
BLMZBloomZ Inc
US$ 0.2054
(4.00%)
9.98M
SRPTSarepta Therapeutics Inc New
US$ 24.58
(33.73%)
9.93M
GTIGraphjet Technology
US$ 0.1098
(5.58%)
9.82M

NCNA Discussion

Ver más
Renee Renee 1 día hace
NCNA: effective August 8,2025 a one for 200 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
👍️0
Matteo2017 Matteo2017 5 días hace
Good God! Don't go by bartchart.com 🤦‍♂️ imo it's crap!
👍️0
gail gail 5 días hace
when I……

….

use bar charts, its only to see what gapped down or up and some of the penny stock charts, i simply jot them down, study how they moved in the past, and decide if they are good to get at the time. but i would never go with their “advice”.

i use finviz the same way. i like to find the highest volume stocks and then go and see why it is and decide as it may be for a bad reason vs just good.
👍️0
moosepass moosepass 5 días hace
LOl, nice jab. No, trading mirrors what barchart lists. Keep up the good work
👍️0
gail gail 5 días hace
bar chart is your guide? wow.
👍️0
moosepass moosepass 5 días hace
Barchart says 100% sell so not really manipulation or panic. Just waiting for the chart to reset to get an entry
👍️0
gail gail 5 días hace
stocktwits is saying that it…..



is only on the offering shares. others are agreeing to that. all that is over my head but it caused panic selling. my hope is it goes back up next week, as it was just popping recently. its all manipulation on all of these, so we just ave to play the game. average down and wait for the next run.
👍️0
moosepass moosepass 5 días hace
So no R/S?
👍️0
gail gail 5 días hace
they just announced an…….



r/s but not for another month and someone posted this, over on stocktwits, so this is good news…

the split is for the ads offering shares which have already been rescinded. This does not pertain to retail and whoever can't produce those shares by August 11th is cooked!
👍️0
gail gail 5 días hace
grabbed some
👍️0
Renee Renee 6 días hace
NCNA: from the June 27th Prospectus: Ordinary shares to be outstanding immediately after this offering

34,540,891,147 ordinary shares (including those ordinary shares represented by ADSs), assuming no Series A ADS Purchase Warrants, or Series A Warrants, are exercised.

That's a lot o' shares!!!

https://www.sec.gov/edgar/search/#/ciks=0001709626&entityName=NuCana%2520plc%2520(NCNA)%2520(CIK%25200001709626)
👍️0
wickerman wickerman 6 días hace
$NCNA Merck could acquire them before cancer drug data:

https://www.reddit.com/r/NucanaPLC/comments/1lvknib/merck_just_bought_veronanext_up_nucana/
👍️0
INV4 INV4 1 semana hace
$NCNA 💹
👍 2
Gatorhide Gatorhide 1 mes hace
Someone on here said Merck was going to present a deal in two weeks. Instead of calling bullshit, I did my research. Meanwhile, the FDA gives Merck “flagship approval” to use its top-selling drug Keytruda. So what, right? Well, let a monkey be my uncle—it just so happens Merck’s FDA approval to expand Keytruda’s use in resectable head and neck squamous cell carcinoma (PD-L1?≥1)—its first perioperative label in this cancer type—is a tailwind for NuCana’s Keytruda-based collaborations. Broader Keytruda use raises baseline demand. As oncologists adopt it in new settings, combo trials like NUC-3373 and NUC-7738 gain traction among prescribers and trial designers. Stronger biotech partnership perception. An expanding label reflects Merck’s confidence in Keytruda’s combinability—NuCana benefits by association, boosting investor and CRO interest. NuCana’s ProTide candidates are built to complement PD-1 blockade. More approved uses ease integration into regimens.
👍 2
TrendTrade2016 TrendTrade2016 1 mes hace
78 million series A warrants....356 million series B warrants....massive s-1 dilution in april and company has no cash...dilute then RS
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
150 million short yesterday and 539 million short tuesday says you have lost your mind...lol...u read too many story boards
👍️0
TOM611 TOM611 1 mes hace
Go. Ncna. Hope. Merck. Says something????
👍️0
TOM611 TOM611 1 mes hace
Go. Ncna. Tripled profit on this. !!!
👍️0
TOM611 TOM611 1 mes hace
Merck. Buyout. Would be awesome
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
NO YA DID NOT CLOWN...U BUY NOTHING...EVER....POPS IN ON HIS WORK BREAK AND PRETENDS
👍️0
gail gail 1 mes hace
i hope that the merck buyout…..

….

for next week, rumor, is true. we need that type of news soon.
👍️0
gail gail 1 mes hace
uh oh, its crashing a/h, maybe it bounces tomorrow.
👍️0
gail gail 1 mes hace
merck that is, too late to edit my prior post.
👍️0
gail gail 1 mes hace
others are posting about merc possibly buying ….

….

out ncna, and the info posted about them downsizing and filing for bk is to position themself for a buy out. thats all over my head but thats what it being said over on stocktwits.
👍️0
gail gail 1 mes hace
no idea, but its going the wrong way.
👍️0
BurgerKing82 BurgerKing82 1 mes hace
How many shares OS? Over 2 billion just traded the other day
👍️0
gail gail 1 mes hace
per google, AI Overview, there is a strong possibility that Merck may be interested in a partnership or acquisition of Nucana due to the promising results of their shared clinical trials.
👍️ 1
gail gail 1 mes hace
wake up e/z, we are on the move!!
👍️0
gail gail 1 mes hace
trying to move back up now. lets go.
👍️0
gail gail 1 mes hace
still dipping. did you ave down?
👍️0
Edgenation Edgenation 1 mes hace
Same! Got in on the little dip!
👍️0
gail gail 1 mes hace
hopped in on the dip here.
👍️ 1
makinezmoney makinezmoney 1 mes hace
$NCNA: Added 60k here at 0.171 here

Lets get a bounce here.


GO $NCNA
👍️ 1
glenn1919 glenn1919 1 mes hace
NCNA.....................................https://stockcharts.com/h-sc/ui?s=NCNA&p=W&b=5&g=0&id=p86431144783
👍️0
TOM611 TOM611 1 mes hace
Go. NCNA.  Weeeeee
👍️0
power11 power11 1 mes hace
fake overvalued markets !!!!!
👍️0
TOM611 TOM611 1 mes hace
Got in that .05 wow I'm up big on this one… Shorts no nothing they always burn to death lol
👍️0
TOM611 TOM611 1 mes hace
Go.  Ncna.  
👍️0
power11 power11 1 mes hace
KEEP DREAMING SENIOR ; THIS IS PURE GARBAGE WRAPPED IN DOG SHIT
AND SPRINKLED WITH CAT SHIT !!!![t][/t]
👍️0
glenn1919 glenn1919 1 mes hace
NCNA......https://stockcharts.com/h-sc/ui?s=NCNA&p=W&b=5&g=0&id=p86431144783
👍️0
Zardiw Zardiw 1 mes hace
#DDAmanda Chart on: $NCNA :









Z
👍️0
Matteo2017 Matteo2017 1 mes hace
Running in pre market 
👍️0
gail gail 1 mes hace
grabbed some.
👍️0
glenn1919 glenn1919 1 mes hace
NCNA..............................https://stockcharts.com/h-sc/ui?s=NCNA&p=W&b=5&g=0&id=p86431144783
👍️0
chumfm chumfm 1 mes hace
Cash alone, this is worth 50 cents per share.Intellectual property value is another 5 to 10 dollars a share.This has a lot of upside.One good FDA report or study release and this rockets pass a buck in a heartbeat.Good luck and good trading.PS:The earnings report showed promise.They are firing on all cylinders.
👍️0
JOHNNY C1 JOHNNY C1 2 meses hace
Thought it was done falling
👍️0
RAlbert RAlbert 2 meses hace
No reason for this drop especially with recent raise in capital above $1. I think we should see the spike to .10,.20,.30 soon from here. Just be patient
👍️ 1
JOHNNY C1 JOHNNY C1 2 meses hace
Took a bite last week at .0458 let's see what Nucana can do
👍️0
chumfm chumfm 2 meses hace
It is certainly unfortunate that the hedge funds control the stock market these days.They and only them price and move the market in their favor.The SEC is no longer an agency that is for the ordinary shareholder.All hedge funds and large corporations have them in their back pockets.Scammers working for these hedge funds are a major problem.Too many sites that feature pumps,cloud clear thinking for the ordinary investor.Take it with a grain of salt,they are not looking after your best interests.Good luck and good trading.
👍️0
RAlbert RAlbert 2 meses hace
Wait for few more days. We can make some profits when the quarterly report is out.

A month ago it is a $1 what would be reason for it drop to cents although there is a new capital injected? Million questions and no answers.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock